-
Can Adalimumab Serve as Big Mac Index for Pharmaceutical Prices?
Sep 9, 2025, 16:22 PM -
German Early Benefit Assessments and the Impact of Medical Societies: An Analysis
Sep 9, 2025, 16:22 PM -
Advancing Real-World Evidence in Diffuse Large B-cell Lymphoma: Insights From EHR-Derived Data in the UK
Sep 9, 2025, 16:22 PM -
Changes in Physical Activity of Pediatric Patients Treated With Damoctocog Alfa Pegol During the Alfa-PROTECT Clinical Trial
Sep 9, 2025, 16:22 PM -
ESMO-MCBS Evaluation and French Derogatory Access Decision: Is There a Correlation?
Sep 9, 2025, 16:22 PM -
The Association Between Average Sales Price Decline and Shortages in Small Molecule Injectable Oncology Therapies With Generic Competition
Sep 9, 2025, 16:22 PM -
Lipid-Lowering Prescription Patterns After a Nonfatal Acute Coronary Syndrome: The Impact of Real-World Evidence on Clinical Practice With LATINO-ACS 2.0
Sep 9, 2025, 16:22 PM -
Health Technology Assessment Landscape for Medical Devices in Europe
Sep 9, 2025, 16:22 PM -
Approaches Used in Assessing the Environmental Sustainability of Digital Health Technologies: A Systematic Review
Sep 9, 2025, 16:22 PM -
Cardiovascular Event Rate and Mortality Among Primary-Prevention Hypercholesterolemia Patients in Japan
Sep 9, 2025, 16:22 PM -
Evaluating the Impact of International Drug Pricing Strategies on Indian State-Level
Sep 9, 2025, 16:22 PM -
Innovative Drug Access in Portugal: An Analysis of Managed Entry Agreements Supporting Public Coverage 2014-2024
Sep 9, 2025, 16:22 PM -
Impact of Nonclinically Driven Inhaler Initiation or Switch on Carbon (CO2) Emissions and Healthcare Costs for COPD Patients Using Single-Inhaler Triple Therapy (SITT)
Sep 9, 2025, 16:22 PM -
Digital Twins: Hype or Hope for Better Health Outcomes
Sep 9, 2025, 16:22 PM -
Concordance Between Patient and Physician Reporting of Symptoms for Metastatic Urothelial Cancer in Europe: A Real-World Survey
Sep 9, 2025, 16:22 PM -
National Competent Authorities’ Experiences With Early Feasibility Study Assessment: Promoting Dialogue, Supporting Sponsors, and Fostering Shared Learning to Harmonize the EU Framework
Sep 9, 2025, 16:22 PM -
Mapping the Rare Disease Diagnostic Odyssey of Today: An Adapted Targeted Literature Review (ATLR)
Sep 9, 2025, 16:22 PM -
A Transitional Reimbursement Mechanism for New Medicinal Products Addressing High Unmet Clinical Need in Greece: Proposal for a Medicines Innovation Fund
Sep 9, 2025, 16:22 PM -
Assessing the Value of the Enzyme Replacement Therapy for Hypophosphatasia (HPP): A Spanish Subanalysis of a Pan-European Multidisciplinary Multicriteria Decision Analysis (MCDA)
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness Analysis of FreeStyle Libre Systems vs. Self-Monitoring of Blood Glucose in People With Type 2 Diabetes on Basal Insulin: An Israeli Healthcare System Perspective
Sep 9, 2025, 16:22 PM
